⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Forge’s Fierce Pharma Week Delivered a Powerhouse Event with Over 3,500 Pharmaceutical and Biotech Decision-Makers and Innovators, Representing a 21% Increase in Attendees Over 2025
globenewswire.com
ABBV
ACAD
AZN
BIIB
BMY
LLY
GILD
PFE
REGN
TEVA
Crystalys Therapeutics Strengthens Board of Directors and Leadership Team as Dotinurad Advances Through Global Phase 3 Development
prnewswire.com
AMGN
ABBV
VIVS
ESPR
Obesity Treatment Landscape 2026: Obesity Competitive Landscape and Clinical Trial Analysis 2026 Examines 200+ Companies and 200+ Drugs
globenewswire.com
LLY
NVO
NBIX
WVE
ALV
PFE
ABBV
AMGN
VKTX
ALNY
Alzheimer's Disease Competitive Landscape and Clinical Trial Analysis Report 2026: More Than 200 Companies and 240 Therapies Assessed
globenewswire.com
LLY
BIIB
JNJ
SNY
ALNY
ABBV
BMY
REGN
XCUR
Global Lupus Nephritis Market to Reach USD 4.08 Billion by 2034 at 8.5% CAGR as Rising Disease Burden and Breakthroughs in Targeted Therapies Accelerate Market Expansion, Says Maximize Market Research
prnewswire.com
PFE
AZN
MRK
BMY
GSK
AMGN
BIIB
JNJ
VRTX
IMVT
ABBV
LLY
SNY
REGN
GILD
BHC
AUR
UCB
Allergan Aesthetics Debuts AA Signature™ in the United States with SKIN360, Its First Multimodal Consultation Approach
prnewswire.com
ABBV
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis
prnewswire.com
ABBV
Psoriatic Arthritis Market Landscape: 6 Key Late-Stage Drugs Set to Drive Future Growth | DelveInsight
globenewswire.com
ABBV
AMGN
JNJ
TAK
UCB
MRK
PFE
GILD
LLY
NVS
AZN
BHC
AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery
prnewswire.com
ABBV
Highlights to be presented at Novo’s Capital Markets Day 2026
globenewswire.com
NVO
LLY
AZN
GILD
JNJ
ABBV
NVS
SAN
ROG
GSK
AMGN
MRK
REGN
PFE
BMY